๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Session 5: Neuroscience I Receptors, Proteins-Chemistry and Pharmacology


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
596 KB
Volume
46
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

โœฆ Synopsis


Monoamine oxidase (MAO) is a key regulatory and protective enzyme because its substrates include many physiologically active amines including neurotransmitters, drugs and dietary amines. It occurs in two different subtypes, MAO A and MAO B which are different gene products and have different substrate and inhibitor specificities (reviewed in Shih et al, 1999). The relative ratios of MAO A and B are both organ and species dependent making it difficult to use animals as a model for humans (Inoue et al., 1999). The purpose of this study is to compare the irreversible MAO A and B radiotracers [ 11 C]clorgyline (CLG) and [ 11 C]L-deprenyl (DEP) and their deuterium substituted counterparts (CLG-D and DEP-D) as tracers for measuring MAO A and B in peripheral organs with respect to isotope effect, binding rate, sensitivity to blood flow, and differences in organ distribution. Deuterium substitution was in the methylene carbon of the propargyl group which is the bond known to be cleaved by MAO oxidation.

CLG

CLG-D DEP DEP-D Methods: CLG and CLG-D were imaged for 60 min with PET in 12 healthy human subjects and the results compared with 9 subjects imaged previously with DEP and DEP-D (Fowler et al., 2002). Normalized uptake was measured from the average uptake at plateau (20-60 min) divided by the plasma integral of tracer from injection to end of study (incorporation quotient, IQ). A 3-O N Cl


๐Ÿ“œ SIMILAR VOLUMES


Session 10: Neuroscience IV, Receptors,
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 576 KB

We report here the radiosynthesis, in vitro, and in vivo characterisation of novel b-amyloid binding radiotracers and compare them to the recently reported [ 11 C]-6-OH-BTA-1, currently being tested in Alzheimer's patients 1 . The compounds in the Table below were radiolabelled with 11 C and their b

Session 6: Neuroscience II Receptors - C
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 657 KB

Figure 1, 1a, hNK1 IC 50 = 67pM) is an NK1 receptor PET ligand that was developed in collaboration with the Turku, Uppsala and Hammersmith PET Centers. One drawback of this tracer is its faster rate of defluorination in nonhuman primates than in humans. It was our desire to improve [ 18 F]SPARQ for

Session 9: Neuroscience III Transporters
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 712 KB

In developing 99m Tc-based radioligands for in vivo study of cardiac adrenergic neurons, we compared the relative uptake of the new 99m Tc-labelled compound 99m Tc-FBPBAT with those of the SPET radiotracer 123 I-MIBG in rat vascular smooth muscle cells and neonatal ventricular cardiac myocytes as es

Session 1: Oncology: Molecular Markers a
๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 832 KB

The epidermal growth factor receptor (EGFR) is an epithelial cell membrane receptor with an intra-cellular tyrosine kinase (TK) component. EGFR-TK is involved in cell signalling critical to proliferation, apoptosis, repair and angiogenesis. More than two thirds of human cancers derive from epithelia